Add BrightSurf on Google Email

Findings expand potential of cancer drug

Researchers have found that a specific blood marker is common among patients with a subset of metastatic colorectal cancer, increasing their chances of responding to the drug. This breakthrough builds on an international clinical trial and could lead to more effective treatment options for patients running out of time.

SourceQueen's University·JournalClinical Cancer Research·DateMay 13, 2016

Ovary removal may increase the risk of colorectal cancer

A new study suggests that removing the ovaries may increase the risk of colorectal cancer in women. Among 195,973 Swedish women who underwent ovary removal between 1965 and 2011, a 30% higher rate of colorectal cancer was found compared to the general population. The risk was even higher for women who had both ovaries removed.

SourceWiley·JournalBJS·DateMay 4, 2016

Statins and colorectal cancer

A large case-control study found that statin use is associated with a reduced risk of colorectal cancer, but the difference in risk between statin users and non-users was not significant. Increased serum cholesterol levels were also independently linked to decreased risk of colorectal cancer.

SourcePLOS·JournalPLOS Medicine·DateApr 26, 2016

Precision prevention of colorectal cancer

Researchers developed a risk prediction model integrating 19 environmental and lifestyle risk factors with 64 common genetic risk factors to identify individuals at high risk of developing colorectal cancer. The model aims to improve colonoscopies for those at higher risk, while avoiding unnecessary procedures for low-risk individuals.

New Canadian recommendation against colonoscopy for routine screening of colorectal cancer

A new Canadian guideline recommends fecal occult blood testing (FOBT) every two years or flexible sigmoidoscopy every 10 years for routine screening of colorectal cancer in asymptomatic, low-risk adults aged 50-74. The guideline also recommends against colonoscopy as a primary screening tool, citing lack of direct evidence.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateFeb 22, 2016

Virtual colonoscopy an alternative to FOB test & colonoscopy for colorectal cancer?

A study published in JNCI Journal of the National Cancer Institute found that virtual colonoscopy had higher detection rates than traditional methods like FIT and OC. The researchers concluded that combination of lower attendance and higher detection rate makes CTC a key factor for optimization of its role in population screening.

SourceOxford University Press USA·JournalJNCI Journal of the National Cancer Institute·DateDec 30, 2015

Low rate of job retention following colorectal cancer diagnosis

A study published in JAMA found that nearly half of working individuals with stage III colorectal cancer lost their jobs due to their diagnosis. However, those with access to paid sick leave were more likely to retain their jobs and experience reduced personal financial burdens. The study highlights the importance of providing paid sic...

SourceJAMA Network·JournalJAMA·DateDec 22, 2015

Research points to why some colorectal cancers recur after treatment

A study at MD Anderson Cancer Center reveals that increased methylation of epidermal growth factor receptors (EGFR) leads to resistance to cetuximab antibody therapy, resulting in poorer clinical outcomes and higher recurrence rates. The study also found that expression of methylation-defective EGFR reduces tumor growth in mice.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalJournal of Clinical Investigation·DateNov 16, 2015

Despite promise, vitamin D and calcium do not reduce colorectal cancer risk

Researchers found no significant difference in new polyp formation between patients with vitamin D and/or calcium supplements and those without. The study's results contradict previous findings in models and smaller human trials, highlighting the need for further research on promising cancer prevention strategies.

SourceUniversity of Colorado Anschutz Medical Campus·JournalNew England Journal of Medicine·DateOct 14, 2015

Changing patient's position helps effectiveness of colonoscopy -- especially on one side

A study found that examining the right side of the colon while patients lie on their left side increases polyp and adenoma detection. This position change also improved distension of the colon, allowing for better visualization. The results suggest a more effective tool for ongoing surveillance and prevention.

SourceAmerican Society for Gastrointestinal Endoscopy·JournalGastrointestinal Endoscopy·DateSep 10, 2015

New strategy improves detection of genetic mutations in hereditary colorectal cancer

A new testing method developed to accurately detect PMS2 gene mutations has been shown to improve diagnosis and support genetic counseling and medical management for individuals with Lynch syndrome. The approach combines targeted capture next-generation sequencing, multiplex ligation-dependent probe amplification, and long-range PCR fo...

SourceElsevier Health Sciences·JournalJournal of Molecular Diagnostics·DateAug 27, 2015

Long-term NSAID use may reduce CRC risk

A population-based case-control study found that long-term, continuous use of low-dose aspirin and nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with decreased colorectal cancer risk. The study also suggests that higher COX-2 selectivity in nonaspirin NSAIDs may offer greater protection.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateAug 24, 2015